Interdisciplinary Occupational and Physical Therapy Approach to Treating Constipation and Fecal Incontinence in

Holly Osborn1, Stacey Reek1, Brittany Anderson2

  • 1Beyond Boundaries Therapy Services, Fargo, North Dakota, USA.

Insights

An interdisciplinary approach using occupational and physical therapy effectively treated constipation and fecal incontinence in children unresponsive to standard medical care. This therapy improved pelvic floor function and confidence over six months.

Area of Science:

  • Pediatric Gastroenterology
  • Pelvic Floor Physical Therapy
  • Occupational Therapy

Background:

  • Constipation and fecal incontinence are common in children, often managed with oral laxatives.
  • Non-pharmacological therapies show promise for children not responding to conventional medical treatments.
  • An interdisciplinary approach integrating occupational and physical therapy (OT/PT) may offer enhanced treatment outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of an interdisciplinary OT/PT approach for pediatric constipation and fecal incontinence.
  • To assess improvements in children refractory to standard medical management.
  • To explore the impact of non-pharmacological interventions on continence and quality of life.

Main Methods:

  • Retrospective chart review and case series of two pediatric patients (ages 4 and 10).
  • Utilized surface electromyography (sEMG) biofeedback for pelvic floor muscle training.
  • Tracked progress every 60 days using a therapy plan of care focusing on muscle coordination, education, emotional regulation, and functional skills.

Main Results:

  • Significant improvements observed in pelvic floor function, emotional regulation, and defecation dynamics over a 6-month period.
  • Both participants experienced decreased constipation and fecal incontinence.
  • Enhanced emotional regulation and increased confidence were reported by both children.

Conclusions:

  • A coordinated physical therapy and occupational therapy approach is effective for treating pediatric constipation and fecal incontinence.
  • This interdisciplinary model successfully achieved full continence in children who did not respond to standard medical treatments.
  • OT/PT provides a viable, non-pharmacological option for managing complex pediatric continence issues.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
294
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
275
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
192
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
268
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
526
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
395